A Smartphone-Based Intervention to Improve Colorectal Cancer Screening in African American Men
- Conditions
- Colorectal Cancer
- Interventions
- Behavioral: ControlBehavioral: CRC mHealth
- Registration Number
- NCT06052202
- Lead Sponsor
- ISA Associates, Inc.
- Brief Summary
The goal of this clinical trial is to test a new smartphone-based program designed to help African American men get screened for colorectal cancer (CRC). The main question it aims to answer is:
° Are African American men who complete the smartphone-based program more likely to get screened for colorectal cancer than men who do not?
Participants will:
* Complete a baseline survey asking about their colorectal cancer screening history and their thoughts and beliefs about colorectal cancer and the medical system.
* Be randomized to receive the new smartphone-based program or to receive text messages containing colorectal cancer education materials designed by the Centers for Disease Control (CDC). The new program sends text messages with information about colorectal cancer. Some of these text messages have links to videos that try to help men overcome anything that may stand in the way of getting screened.
* Complete a follow-up survey 6 months after the baseline survey. This survey will ask the same questions as the baseline survey.
* A medical records review will be conducted at 6 months to verify whether participants received a colorectal cancer screening test during the study period.
Researchers will compare participants who receive the new smartphone-based program to participants who receive the CDC information. The goal is to see whether the smartphone-based program increasing screening more than standard educational materials available on the internet.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 128
- African American/Black
- not compliant with current United States Preventive Services Taskforce colorectal cancer screening recommendations
- owns a mobile phone capable of text messaging and accessing webpages
- able to speak/understand English
- personal history of colorectal cancer
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Control Education Control Control condition participants will receive information about colorectal cancer and screening developed by the Centers for Disease Control. CRC mHealth intervention CRC mHealth Experimental group participants will have access to the CRC mHealth intervention.
- Primary Outcome Measures
Name Time Method Receipt of Colorectal Cancer Screening Test at Month 6 Month 6 Whether or not a participant received a colorectal cancer screening test since beginning the study. The date and type of screening will be verified via electronic medical records. A value of "0" will be recorded if no screening test is found in the electronic health record. A value of "1" will be recorded if a screening test is found in the electronic health record.
- Secondary Outcome Measures
Name Time Method Change from Baseline in Perceived Benefits to Stool Test at Month 6 Baseline and Month 6 Measured using Rawl and colleagues' (2001) 5-item perceived benefits to fecal occult blood test scale. Items are averaged to form a score ranging from 0 to 4 with higher scores indicating higher perceived benefits to stool tests.
Change from Baseline in Cancer Fatalism at Month 6 Baseline and Month 6 Measured using the 15-item Powe Fatalism Inventory. Items are averaged to form a score ranging from 0 to 4 with higher scores indicating higher cancer fatalism beliefs.
Change from Baseline in Perceived Susceptibility to Colorectal Cancer at Month 6 Baseline and Month 6 Measured using the 5-item perceived susceptibility subscale of Green and colleagues' (2004) CRC Knowledge, Perceptions, and Screening Survey. Items are averaged to form a score ranging from 0 to 4 with higher scores indicating higher perceived susceptibility.
Change from Baseline in Colorectal Cancer Knowledge at Month 6 Baseline and Month 6 Measured using the 16-item CRC Knowledge test subsection of Green and colleagues' (2004) CRC Knowledge, Perceptions, and Screening Survey. The true/false items are scored 1 (correct) or 0 (incorrect) and summed to form a score ranging from 0 to 16. Higher scores indicate greater colorectal cancer knowledge.
Change from Baseline in Perceived Benefits to Colonoscopy at Month 6 Baseline and Month 6 Measured using Rawl and colleagues' (2001) 5-item perceived benefits to colonoscopy scale. Items are averaged to form a score ranging from 0 to 4 with higher scores indicating higher perceived benefits to colonoscopy.
Change from Baseline in Perceived Severity of Colorectal Cancer at Month 6 Baseline and Month 6 Measured using the 12-item perceived severity subscale of Green and colleagues' (2004) CRC Knowledge, Perceptions, and Screening Survey. Items are averaged to form a score ranging from 0 to 4 with higher scores indicating higher perceived severity.
Trial Locations
- Locations (1)
ISA Associates, Inc.
🇺🇸Alexandria, Virginia, United States